📌 Key Takeaways
- Topic: Silica Supplier Mexico: Sourcing Options, Producers and Import Tips
- Keywords: silica polishing agent
- Published: 2026-11-20 04:11:13
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
What Is Hollow Silica? Structure, Properties and Applications
- Alumina Powder vs Silica Powder: Properties, Uses and How to Choose
- 53. Kramarczyk D., Knapik-Kowalczuk J., Smolka W., Monteiro M.F., Tajber L., Paluch M. Inhibition of celecoxib crystallization by mesoporous silica - Molecular dynamics studies leading to the discovery of the stabilization origin. Eur. J. Pharm. Sci. 2022;171:106132. doi: 10.1016/j.ejps.2022.106132. [ DOI ] [ PubMed ] [ Google Scholar ]
- Silica Supplier Turkey: Market Overview, Producers and Import Options
- 45. Knapik-Kowalczuk J., Kramarczyk D., Chmiel K., Romanova J., Kawakami K., Paluch M. Importance of mesoporous silica particle size in the stabilization of amorphous pharmaceuticals - The case of simvastatin. Pharmaceutics. 2020;12:384. doi: 10.3390/pharmaceutics12040384. [ DOI ] [ PMC free article ] [ PubMed ] [ Google Scholar ]
- Silica MSDS: How to Read It and What Safety Information to Check
- Keywords: mesoporous silica, nanoparticles, drug delivery, toxicity, functionalization, stimuli-responsive
- What Is TEOS? Uses in Sol-Gel Silica, Coatings and Semiconductors
- 104. Vialpando M., Backhuijs F., Martens J.A., Van Den Mooter G. Risk assessment of premature drug release during wet granulation of ordered mesoporous silica loaded with poorly soluble compounds itraconazole, fenofibrate, naproxen, and ibuprofen. Eur. J. Pharm. Biopharm. 2012;81:190-198. doi: 10.1016/j.ejpb.2012.01.012. [ DOI ] [ PubMed ] [ Google Scholar ]
What Is Tetraethyl Orthosilicate? Properties, Uses and Role in Silica Synthesis
What is silica (SiO₂)?
spherical silica powder
What is the difference between fumed silica and precipitated silica?
how to modify nano silica Targeted therapy, aiming, for instance, at antitumor treatments, can be divided into active and passive forms [ 72, 73 ]. Passive targeting is based on higher vascularity and higher vascular permeability of the tumor, as well as inflamed tissues, compared to physiological ones [ 73, 74 ]. Additionally, the lymphatic circulation of the tumor shows decreased efficiency [ 25 ], which led to easier accumulation of nanoparticles in the tumor or inflamed tissues [ 10, 27, 72, 74 ]. This passive accumulation is normally called "ELVIS" (Extravasation through Leaky Vasculature and later Inflammatory cell-mediated Sequestration) [ 72, 74 ]. From the facet of surface qualities, negatively charged nanoparticles accumulate less effectively inside cells, due to the negatively charged cell membrane, which slows down the cellular uptake, so, in this case, a neutral surface charge is more favorable [ 25 ]. In contrast, active targeting can be accomplished by functionalizing the outer surface of the silica carriers [ 10, 27, 72 ], where molecules are attached to the surface of the carriers that specifically bind to certain cell surface ligands and receptors, which are characteristic of tumor-, but not of healthy cells. This selective method provides more effective treatment and reduces the side impacts of cytotoxic APIs on healthy cells and tissues [ 10, 27 ]. The most recent findings on active targeting possibilities are summarized in Table 3. García-Fernández et al. prepared a mesoporous silica-based nanocarrier loaded with dexamethasone and capped with a particular protein to actively target the TNFR1 receptor, which is overexpressed in pro-inflammatory macrophages [ 72 ]. Since the carriers are preferably internalized by these macrophages, the cargo is released in a controlled manner, during enzymatic hydrolysis, thus preventing premature drug release, thanks to the gatekeepers. The targeting talent was tested in vitro with activated macrophages. On the other hand, the therapeutic efficiency was tested in vivo in mouse models. The researchers observed greater therapeutic impacts and fewer adverse side influences than in the case of free dexamethasone. To sum up, dexamethasone-loaded MSN has been effectively developed to actively target the lungs in acute lung injury (ALI), and this result may also be promising in other lung diseases (COPD, asthma) [ 72 ]. Teruel et al. presented a novel approach in oral inflammatory bowel sickness (IBD) therapy, using functionalized magnetic mesoporous silica microparticles [ 75 ].
What drives silica raw material prices?
silica specification sheet
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.